Infinity Pharmaceuticals Inc (INFI)

1.01 +0.03  +3.48% NASDAQ Nov 18, 16:59 Delayed 2m USD

Infinity Pharmaceuticals Cash from Investing (TTM):

-21.74M for Sept. 30, 2019
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Investing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Investing (TTM) Data

View and export this data going back to 2000. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2019 -21.74M
June 30, 2019 -20.43M
March 31, 2019 -0.294M
Dec. 31, 2018 13.10M
Sept. 30, 2018 12.84M
June 30, 2018 0.768M
March 31, 2018 -16.49M
Dec. 31, 2017 -4.278M
Sept. 30, 2017 -7.257M
June 30, 2017 26.10M
March 31, 2017 80.81M
Dec. 31, 2016 40.33M
Sept. 30, 2016 11.22M
June 30, 2016 37.47M
March 31, 2016 -74.52M
Dec. 31, 2015 -37.90M
Sept. 30, 2015 25.74M
June 30, 2015 -14.24M
March 31, 2015 103.53M
Dec. 31, 2014 117.85M
Sept. 30, 2014 136.54M
June 30, 2014 162.62M
March 31, 2014 80.84M
Dec. 31, 2013 0.606M
Sept. 30, 2013 -64.97M
   
June 30, 2013 -140.98M
March 31, 2013 -123.56M
Dec. 31, 2012 -62.00M
Sept. 30, 2012 -86.87M
June 30, 2012 -22.32M
March 31, 2012 -14.34M
Dec. 31, 2011 -13.69M
Sept. 30, 2011 37.42M
June 30, 2011 27.89M
March 31, 2011 37.41M
Dec. 31, 2010 30.48M
Sept. 30, 2010 10.69M
June 30, 2010 32.77M
March 31, 2010 25.85M
Dec. 31, 2009 -7.496M
Sept. 30, 2009 -46.44M
June 30, 2009 -46.01M
March 31, 2009 -61.05M
Dec. 31, 2008 -18.18M
Sept. 30, 2008 37.69M
June 30, 2008 20.93M
March 31, 2008 25.14M
Dec. 31, 2007 -62.00M
Sept. 30, 2007 -61.13M
June 30, 2007 -64.15M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Cash From Investing

An item on a company's cash flow statement. Lists aggregate change in cash position resulting from investing activities. Includes the company's cash inflows and outflows from investments in financial markets and the sale of capital assets.
Learn More

Advertisement

Cash from Investing (TTM) Benchmarks

Benchmarks
Bristol-Myers Squibb Co 1.93B
Arcus Biosciences Inc 73.83M
Merck & Co Inc 312.00M

Cash from Investing (TTM) Range, Past 5 Years

Minimum -74.52M Mar 2016
Maximum 117.85M Dec 2014
Average 13.63M
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.